Anti-Kv1.4 Antibody-positive Nivolumab-induced Myasthenia Gravis and Myositis Presenting with Bilateral Ptosis and Demonstrating Different Pathophysiologies

Nivolumab blocks inhibitors of T-cell activation and restores antitumor immunity but promotes T-cell activity in host tissues by blocking inhibition of the T-cell function, resulting in immune-related adverse effects. We herein report an 80-year-old man presenting with nivolumab-related myasthenia g...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitazaki, Yuki, Yamamura, Osamu, Usui, Kojiro, Ueno, Asako, Sanada, Sayaka, Sasaki, Hirohito, Endo, Yoshinori, Enomoto, Soichi, Ikawa, Masamichi, Nakamoto, Yasunari, Hamano, Tadanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641203/
https://www.ncbi.nlm.nih.gov/pubmed/37839874
http://dx.doi.org/10.2169/internalmedicine.0739-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641203/
https://www.ncbi.nlm.nih.gov/pubmed/37839874
http://dx.doi.org/10.2169/internalmedicine.0739-22

Ejemplares similares